A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...

May 21, 2025 • We asked some of our trusted critics which upcoming books they are most looking forward to. Here are the fiction and nonfiction titles they picked. November 25, 2024 • Books We ...

He served as the science, environment and aerospace correspondent and the anchor of various programs, including American Morning. While at CNN, O’Brien secured a deal with NASA to become the ...